Product
Supplier
Encyclopedia
Inquiry
Home > Active Pharmaceutical Ingredients > Other Chemical Drugs > Semaglutide for Sale > Semaglutide Lyophilized Powder CAS 910463-68-2 Research Grade Peptide Raw Material
Semaglutide Lyophilized Powder CAS 910463-68-2 Research Grade Peptide Raw Material buy - large image1
Semaglutide Lyophilized Powder CAS 910463-68-2 Research Grade Peptide Raw Material buy - image1
Semaglutide Lyophilized Powder CAS 910463-68-2 Research Grade Peptide Raw Material buy - image2
Semaglutide Lyophilized Powder CAS 910463-68-2 Research Grade Peptide Raw Material buy - image3
Semaglutide Lyophilized Powder CAS 910463-68-2 Research Grade Peptide Raw Material buy - image4
Semaglutide Lyophilized Powder CAS 910463-68-2 Research Grade Peptide Raw Material buy - image5
Semaglutide Lyophilized Powder CAS 910463-68-2 Research Grade Peptide Raw Material buy - image6

Semaglutide Lyophilized Powder CAS 910463-68-2 Research Grade Peptide Raw Material

420 Inquiries

Unit Price:

$56/UNIT FOB

Get Latest Price
CAS No.:

910463-68-2

Grade:

Pharmaceutical Grade

Content:

99%

Port:

shenzhen

Brand:

ZHONGMA

Packaging:

10mg per vial; 10vials/box

Sample Available:

Yes

Price valid (until):

2027-03-09

Company Type:
Trader
Location:
China
Payment Terms:
TT against copy of documents,100% TT in advance
Average Lead Time:
1 days
Qualification:
Main Products:

GLP-1,Retatrutide,Tirzepatide,Peptides

  • Product Details

  • Seller Information

  • Inquiry History

  • Description

    Sales manager:  Nyra
    whatsapp:+86 18830996705
    Email:  Nyra@hzzmtrade.cn


      What is semalutide?  


    Somalutide is a long-acting formulation developed based on the basic structure of liraglutide, and it is more effective in treating type 2 diabetes.
    English name: Semaglutide
    CAS number: 910463-68-2

    Molecular formula:C187H291N45O59

    Appearance: White Powder

    Purity (HPLC): ≥99.0%

    Storage: Store at -20℃ degrees Celsius in a dry and cool place.

    Storage Condition: Store at -20°C Solubility in DMSO: 3mg/mL (0.73 mM)

    Drug type: Long-acting GLP-1 receptor agonists exert their therapeutic effects by mimicking the actions of natural GLP-1.
        Semaglutide is currently widely used in clinical practice as a GLP-1 receptor agonist. It has gained prominence due to its convenience of once-weekly administration, significant glycemic control and weight reduction effects, as well as its protective benefits for cardiovascular health, making it an important drug for managing type 2 diabetes and obesity. However, its use must strictly follow medical guidance, starting with a low dose, monitoring adverse reactions, and ensuring safety and efficacy.

    Semaglutide produces multiple physiological effects by activating GLP-1 receptors:
        Regulating blood glucose: Promotes insulin secretion (only when blood sugar levels rise, glucose-dependent, reducing the risk of hypoglycemia); inhibits glucagon secretion (reduces hepatic glucose production); delays gastric emptying, slowing the absorption rate of carbohydrates.
        Weight loss effect: Acts on the central nervous system (hypothalamus), increasing satiety, reducing appetite and food intake; may increase energy expenditure by regulating energy metabolism .

    Product name
    Semaglutide
    CAS No.
    910463-68-2
    Specifications 10mg per vial; 10vi als/box
    MNQ 1 box of 10 vials
    Physical State Solid
    Funktion loose weight
    Storage Cool Dry Plac

    Shop Semaglutide Lyophilized Powder CAS 910463-68-2 Research Grade Peptide Raw Material-Detailed Image 1 Shop Semaglutide Lyophilized Powder CAS 910463-68-2 Research Grade Peptide Raw Material-Detailed Image 2 Shop Semaglutide Lyophilized Powder CAS 910463-68-2 Research Grade Peptide Raw Material-Detailed Image 3 Shop Semaglutide Lyophilized Powder CAS 910463-68-2 Research Grade Peptide Raw Material-Detailed Image 4 Shop Semaglutide Lyophilized Powder CAS 910463-68-2 Research Grade Peptide Raw Material-Detailed Image 5



      About Us  


    Zhongma Technology is an integrated high‑tech enterprise engaged in R&D, manufacturing and global export of peptide raw materials. We concentrate on supplying high‑purity research‑grade synthetic peptides, multi‑receptor agonist peptides and biochemical fine‑chemical intermediates, catering to research laboratories, biotech firms and scientific institutions worldwide.
    Our in‑house R&D team consists of seasoned industry specialists and elite young technical talents. Drawing on deep‑rooted expertise and rich hands‑on experience in peptide synthesis, we continuously optimize manufacturing workflows, overcome technical challenges, and launch innovative peptide products with proprietary intellectual property rights. We also maintain long‑term technical collaboration with prestigious domestic and international research institutes, driving technological progress across the global peptide industry.
    Guided by pragmatism, innovation, strictness and commitment, Zhongma Technology sticks to the business principle of quality priority, customer centricity and integrity‑oriented operation. Specializing in R&D, production and distribution of high‑purity biochemical and peptide research materials, we run standardized production facilities supported by a comprehensive quality management system. Every production stage undergoes stringent inspection to guarantee high purity, stable performance and consistent batch quality, delivering dependable raw‑material solutions for global clients’ research projects.
    Shop Semaglutide Lyophilized Powder CAS 910463-68-2 Research Grade Peptide Raw Material-Detailed Image 6


    Supporting Logistics Services
    1.Goods: Neutral packaging, no company logo, compliant with export customs clearance requirements;
    2.The shipping tracking number will be provided to the customer 1–2 business days after shipment and can be tracked in real time;
    3.After shipment, we will provide customs clearance documents and shipping documents;
    4.Lost Items / Withheld Items / Free Replacement for Items Failing Customer Inspection

    Advantages of the source factory

    1. We strictly control the purity of our raw materials to ensure high peptide content, low impurity levels, and excellent product stability. After freeze-drying, the product appears as a uniform white powder with resistance to inactivation.
    2. We manufacture in our own facility using a fully integrated, closed-loop production process. There are no markups from middlemen. We support bulk orders, are capable of handling large-scale production, maintain ample inventory, and ensure predictable delivery times.
    3. We use vacuum freeze-drying technology to maximize the retention of peptide bioactivity. These vials are securely sealed, making them easy to store and transport, and resistant to spoilage.
    4. We are familiar with cross-border export channels and can arrange specialized logistics services such as DHL and FedEx. We use shock-resistant and shatter-proof packaging to minimize the risk of damage during transit and provide prompt shipping responses.
    5. We provide product information, track shipment status, and efficiently handle order inquiries.

    6.Our factory puts customers first and is quality-driven. Strict quality control is implemented throughout the entire production process. We respect the needs of every customer, provide products of consistent quality, ensure efficient communication, and deliver reliably, growing together with our customers worldwide.


    Our Services  


    Shipping Methods

    We offer multiple international shipping options, including DHL, FedEx, UPS, and US Special Line. The available shipping method will be selected according to the destination, package requirements, and current carrier availability. Tracking information will be provided after dispatch. Shipping time and customs clearance may vary by destination.

    Shop Semaglutide Lyophilized Powder CAS 910463-68-2 Research Grade Peptide Raw Material-Detailed Image 7 Shop Semaglutide Lyophilized Powder CAS 910463-68-2 Research Grade Peptide Raw Material-Detailed Image 8

    Payment Methods

    We currently accept Bitcoin, USDT, bank transfer, and Wise. Please confirm the order total, payment currency, transfer fees, and receiving details with us before making payment. Orders will be arranged after the payment has been received and verified.

    closed deals:

    Shop Semaglutide Lyophilized Powder CAS 910463-68-2 Research Grade Peptide Raw Material-Detailed Image 9 Shop Semaglutide Lyophilized Powder CAS 910463-68-2 Research Grade Peptide Raw Material-Detailed Image 10

    ECHEMI Editorial Reference

    Semaglutide (CAS: 910463‑68‑2) is a synthetic lipid‑modified peptide analogue, consisting of a 31‑amino‑acid backbone with a covalently attached C18 fatty di‑acid side‑chain via a hydrophilic spacer. It shares 94% amino‑acid sequence homology with native human GLP‑1 peptide. The substance appears as white to almost white hygroscopic powder, with molecular formula C₁₈₇H₂₉₁N₄₅O₅₉ and molecular weight of 4113.58 g/mol. Structural modifications grant it resistance against DPP‑4 enzymatic degradation and enable reversible binding to serum albumin, contributing to its extended in‑vivo half‑life property.

    Basic Info
    Product Name:

    Semaglutide

    Other Name:

    Sermaglutide;Semaglutide impurity;Sermaglutide USP/EP/BP;semaglutide;Sermaglutide CAS 910463 68 2;Semaglutide (H-7894.0001);semgalutide;Semaglutide

    CAS No.:

    910463-68-2

    Molecular Formula:

    C187H291N45O59

    InChIKeys:

    DLSWIYLPEUIQAV-CCUURXOWSA-N

    Molecular Weight:

    4113.57754

    Exact Mass:

    4113.122087 g/mol

    EC Number:

    203-405-2

    Color/Form:

    White to off-white

    Categories:

    Other Chemical Drugs

    Characteristics
    PSA:

    1650 Ų

    XLogP3:

    5.44520

    Critical Temperature & Pressure:

    Store at -20°C

    Research
    Class:

    GLP-1R agonist

    Status:

    FDA-approved (Ozempic / Wegovy / Rybelsus)

    Mechanism:

    Long-acting, selective glucagon-like peptide-1 (GLP-1) receptor agonist with 94% sequence homology to human GLP-1. Engineered for extended half-life (~1 week) via albumin binding (fatty acid acylation at Lys26) and resistance to DPP-4 degradation (Aib substitution at position 8). Promotes insulin secretion, inhibits glucagon release, delays gastric emptying, and reduces appetite via central nervous system GLP-1R activation.

    Activity note:

    Potent, selective GLP-1R agonist. Reported binding affinity Ki = 0.38 ± 0.06 nM. Semaglutide is a human GLP-1 analog with structural modifications for albumin binding (C18 fatty diacid at Lys26) and enzymatic stability (Aib8 substitution).

    Source:

    Lau J, et al. J Med Chem. 2015;58(18):7370-7380. Wilding JPH, et al. N Engl J Med. 2021;384(11):989-1002.DOI

    Clinical Development:

    NCT03548935; NCT03552757; NCT01720446; NCT02692716

    FDA:

    Ozempic, Wegovy, Rybelsus (approved 2017-12-05)

    References
    ChEMBL:

    CHEMBL2108724

    DrugBank:

    DB13928

    KEGG DRUG:

    D10025

    PubChem:

    PubChem

    Disclaimer:

    Semaglutide is approved as a prescription medicine (Ozempic, Wegovy, Rybelsus) in certain jurisdictions. This listing is for industrial and laboratory research use only. Research-chemical listings on B2B marketplaces are not interchangeable with approved medicines. Confirm CAS, specification, and regulatory pathway with the seller. It is not medical advice, a clinical recommendation, or an approved therapy description.

    Hazard Identification

    Classification of the substance or mixture

    Reproductive toxicity, Category 2

    GHS label elements, including precautionary statements

    Pictogram(s)
    Signal word

    Warning

    Hazard statement(s)

    H361 Suspected of damaging fertility or the unborn child

    Precautionary statement(s)
    Prevention

    P203 Obtain, read and follow all safety instructions before use.

    P280 Wear protective gloves/protective clothing/eye protection/face protection/hearing protection/...

    Response

    P318 IF exposed or concerned, get medical advice.

    Storage

    P405 Store locked up.

    Disposal

    P501 Dispose of contents/container to an appropriate treatment and disposal facility in accordance with applicable laws and regulations, and product characteristics at time of disposal.

    Other hazards which do not result in classification

    no data available

    Handling and Storage

    Precautions for safe handling

    Handling in a well ventilated place. Wear suitable protective clothing. Avoid contact with skin and eyes. Avoid formation of dust and aerosols. Use non-sparking tools. Prevent fire caused by electrostatic discharge steam.

    Conditions for safe storage, including any incompatibilities

    Store the container tightly closed in a dry, cool and well-ventilated place. Store apart from foodstuff containers or incompatible materials.

  • Seller Information
    Business Type:

    Trader

    Main Products:

    GLP-1,Retatrutide,Tirzepatide,Peptides

    Location:

    Room A008, 704#, Building 11, Shiliu Street Block, Liangzhu Subdistrict, Yuhang District, Hangzhou City, Zhejiang Province

    Payment Terms:

    TT against copy of documents,100% TT in advance

    Average lead Time:

    1 days

    Total Annual Revenue:

    $1 million-$2.5 million

    Total Employees:

    11-50

    Year of Establishment:

    2025

    Hangzhou Zhongma Trading Co., Ltd. is an international trading company based in Hangzhou, China. We support customers worldwide with product sourcing, order coordination, documentation, packaging options, and logistics arrangements.

    With a focus on clear communication and responsive service, we work closely with supply partners to help customers manage product selection, batch documentation, and delivery requirements. We value long-term cooperation and aim to provide practical, reliable solutions tailored to each customer’s needs.

  • Inquiry History
    420 Inquiries
    Country Product Purchase Quantity Date Posted
    Austria

    CBL-514

    500 MG Oct 28, 2026
    United Kingdom

    Semaglutide

    1 G Oct 27, 2026
    Belgium

    Semaglutide

    1 MT Oct 19, 2026
    Chile

    Semaglutide

    10 MG Oct 16, 2026
    Slovakia

    semaglutide

    10 MG Oct 15, 2026
    Germany

    Semaglutide

    1 G Oct 14, 2026
    South Africa

    Semaglutide

    10 MT Oct 11, 2026
    United States

    Semaglutide

    1000 MT Oct 6, 2026
    United States

    Semaglutide

    10 MT Sep 30, 2026
    United States

    Semaglutide

    1000 KG Sep 30, 2026
    United States

    Semaglutide

    30 MG Sep 28, 2026
    United States

    Semaglutide

    10 MT Sep 25, 2026
    Philippines

    Semaglutide

    10 MG Sep 20, 2026
    India

    Semaglutide

    10 MG Sep 18, 2026
    United Kingdom

    Semaglutide - Reta - Tirz

    100 MG Sep 17, 2026
    United Kingdom

    Semaglutide

    10 G Sep 17, 2026
    United Kingdom

    Retatruide

    1 MT Sep 15, 2026
    United Kingdom

    IGF-1 LR3

    10 MT Aug 28, 2026
    Paraguay

    Semaglutide Freeze-dried Vial

    1 KG Aug 27, 2026
    United States

    Semaglutide

    2 MT Aug 25, 2026
    Post an enquiry for this product
pic ×

Scan the QR Code to Share

All products displayed on this website are only for non-medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.

According to relevant laws and regulations and the regulations of this website, units or individuals who purchase hazardous materials should obtain valid qualifications and qualification conditions.

The information shown above is provided by the enterprise itself, and the authenticity, accuracy and legitimacy of the content are the responsibility of the publishing company. ECHEMI does not bear any guarantee responsibility for this. Please be aware that risks in internet transactions objectively exist.

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.